Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
03-2022 | 03-2021 | 03-2020 | 03-2019 | 03-2018 | |
Cash Flows From Operating Activities | |||||
Net Income | 136,505 | 225,525 | 203,009 | 259,016 | 112,170 |
Depreciation Amortization | 28,089 | 24,097 | 20,430 | 14,121 | 11,005 |
Income taxes - deferred | 2,413 | 29,380 | 32,953 | -7,745 | 42,624 |
Accounts receivable | 5,335 | -12,059 | 5,551 | -22,023 | -15,289 |
Accounts payable and accrued liabilities | 641 | 2,629 | 2,581 | 7,976 | 4,412 |
Other Working Capital | -30,196 | -17,386 | 8,025 | -38,841 | -18,927 |
Other Operating Activity | 142,603 | 22,392 | 42,371 | 39,693 | 56,551 |
Operating Cash Flow | $285,390 | $274,578 | $314,920 | $252,197 | $192,546 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -243,637 | -159,556 | -60,492 | -29,716 | -118,499 |
PPE Investments | -35,763 | -53,383 | -44,006 | -44,004 | -55,863 |
Net Acquisitions | -82,821 | -52,183 | N/A | N/A | N/A |
Purchase Of Investment | -18,769 | -26,104 | -20,957 | -42,735 | -6,400 |
Other Investing Activity | 0 | 67,882 | 0 | 0 | 0 |
Investing Cash Flow | $-380,990 | $-223,344 | $-125,455 | $-116,455 | $-180,762 |
Cash Flows From Financing Activities | |||||
Debt Repayment | N/A | N/A | N/A | N/A | -517 |
Common Stock Issued | 16,658 | 14,554 | 8,851 | 16,001 | 11,697 |
Common Stock Repurchased | 0 | -11,310 | -84,879 | 0 | N/A |
Other Financing Activity | -18,860 | -11,311 | -41,687 | -71,776 | -20,317 |
Financing Cash Flow | $-2,202 | $-8,067 | $-117,715 | $-55,775 | $-9,137 |
Exchange Rate Effect | -2,090 | -2,798 | -430 | -1,921 | 1,288 |
Beginning Cash Position | 232,710 | 192,341 | 121,021 | 42,975 | 39,040 |
End Cash Position | 132,818 | 232,710 | 192,341 | 121,021 | 42,975 |
Net Cash Flow | $-99,892 | $40,369 | $71,320 | $78,046 | $3,935 |
Free Cash Flow | |||||
Operating Cash Flow | 285,390 | 274,578 | 314,920 | 252,197 | 192,546 |
Capital Expenditure | -35,763 | -53,383 | -44,006 | -44,004 | -55,863 |
Free Cash Flow | 249,627 | 221,195 | 270,914 | 208,193 | 136,683 |